More about Fortis Healthcare Limited
Fundamentals for Fortis Healthcare Limited
Regulatory Filings for Fortis Healthcare Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Fortis Healthcare Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was founded in 1995 and is based in Gurugram, India.
Revenue projections:
Investors may be wary of Fortis Healthcare Limited as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.
Financial Ratios:
| currentRatio | 0.00000 |
|---|---|
| forwardPE | 48.28185 |
| debtToEquity | 32.95800 |
| earningsGrowth | -0.21600 |
| revenueGrowth | 0.17500 |
| grossMargins | 0.57685 |
| operatingMargins | 0.17020 |
| trailingEps | 12.71000 |
| forwardEps | 19.07549 |
FORTIS's low earnings and revenue growth suggest that the company's profits may shrink. This trend could indicate underlying financial struggles and pose challenges for FORTIS's future profitability.
FORTIS's negative gross and operating margins indicate that the company is currently unprofitable at both the production and operational levels. This suggests significant challenges in managing costs and generating revenue, which could impact its overall financial health.
FORTIS's forward EPS is higher than its trailing EPS, suggesting the company is expected to improve its profitability this financial year. This reflects growing confidence in FORTIS's earnings potential, with forecasts indicating better financial performance than in the prior year.
Price projections:
FORTIS's stock price has regularly been near the lower end of projections, indicating that it may be struggling to attract investor interest. This pattern suggests a cautious sentiment surrounding the company's future performance.
Recommendation changes over time:
The recent buy bias for Fortis Healthcare Limited from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see Fortis Healthcare Limited as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction